14-day Premium Trial Subscription Sign Up For FreeGet Free

Celyad SA Stock Forecast NASDAQ:CYAD

Price Target and Analyst Ratings

Most Recent Rating

On August 20, 2021 "Jonestrading" gave "" rating for CYAD. The price target was changed from $4.02 to 2.0%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-20 Reiterated by Jonestrading $3.88 $4.02→2.0%
2021-08-06 $17.00 - $15.00 Target Lowered by HC Wainwright $4.30 $4.29+0.7%
2021-05-17 Buy Target Lowered by HC Wainwright $5.57 $18.00 → $17.00
2021-05-10 Buy Target Lowered by HC Wainwright $5.71 $18.00 → $17.00
2021-03-31 Buy - Hold Reiterated by Jonestrading $7.03
2021-03-25 Buy - Hold Downgraded by Jonestrading $7.30
2020-12-08 Buy Target Lowered by HC Wainwright $8.08 $22.00 → $18.00
2020-09-29 Buy Reiterated by William Blair $9.90
2020-06-01 Buy Reiterated by William Blair $12.47
2020-05-07 Buy Reiterated by HC Wainwright $8.94

CYAD Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -14.83% during the next 3 months and, with a 90% probability hold a price between $3.08 and $4.02 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-22 $3.61 $4.16 $4.70
2021-09-23 $3.59 $4.14 $4.69
2021-09-24 $3.58 $4.13 $4.68
2021-09-27 $3.57 $4.12 $4.67
2021-09-28 $3.55 $4.10 $4.65
2021-09-29 $3.54 $4.09 $4.64
2021-09-30 $3.53 $4.08 $4.63
2021-10-01 $3.51 $4.06 $4.61
2021-10-04 $3.50 $4.05 $4.60
2021-10-05 $3.49 $4.04 $4.59
2021-10-06 $3.48 $4.02 $4.57
2021-10-07 $3.46 $4.01 $4.56
2021-10-08 $3.45 $4.00 $4.55
2021-10-11 $3.44 $3.99 $4.53
2021-10-12 $3.42 $3.97 $4.52
2021-10-13 $3.41 $3.96 $4.51
2021-10-14 $3.40 $3.95 $4.50
2021-10-15 $3.38 $3.93 $4.48
2021-10-18 $3.37 $3.92 $4.47
2021-10-19 $3.36 $3.91 $4.46
2021-10-20 $3.35 $3.89 $4.44
2021-10-21 $3.33 $3.88 $4.43
2021-10-22 $3.32 $3.87 $4.42
2021-10-25 $3.31 $3.86 $4.40
2021-10-26 $3.29 $3.84 $4.39
2021-10-27 $3.28 $3.83 $4.38
2021-10-28 $3.27 $3.82 $4.37
2021-10-29 $3.25 $3.80 $4.35
2021-11-01 $3.24 $3.79 $4.34
2021-11-02 $3.23 $3.78 $4.33

About Celyad SA

Celyad SA Celyad SA, a clinical-stage biopharmaceutical company, focuses on engineered cell therapy treatments. It develops therapeutic therapies for the treatment of unmet medical needs in cardiology and oncology. The company offers C-Cure, an autologous cell therapy for the treatment of heart failure. It also provides NKR-2, an autologous chimeric antigen receptor (CAR), a lab engineered receptor for the treatment of cancer. In addition, the company’s p... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT